New study tracks CF Drug's impact on Kids' lungs and lives
Disease control
Completed
This study followed 125 children aged 6-11 with cystic fibrosis who were prescribed a triple therapy (elexacaftor, tezacaftor, and ivacaftor). Researchers measured changes in sweat chloride, lung function, and weight over 24 months to see how well the treatment works in real life…
Sponsor: Nicole Hamblett • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC